Atricure Inc 7555 Innovation Waywest Chester Oh 45040 Pma Numberp200002 Supplement Numbers003 Date Received09 13 2022 Decision Date10 13 2022 Product Code Ocm Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Atricure Inc 7555 Innovation Waywest Chester Oh 45040 Pma Numberp200002 Supplement Numbers003 Date Received09 13 2022 Decision Date10 13 2022 Product Code Ocm Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P200002S003 AtriCure, Inc.7555 Innovation Waywest Chester, OH 45040 PMA NumberP200002 Supplement NumberS003 Date Received09/13/2022 Decision Date10/13/2022 Product Code OCM  Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	EPi-Sense® Guided Coagulation System and EPi-Sense ST™ Coagulation System	2022-10-13